Patents Assigned to Max Zeller Soehne AG
  • Pharmacological use of extract
    Patent number: 11541093
    Abstract: The present invention relates to the novel use of an extract from a Cimicifuga species, preferably Cimicifuga racemosa (also termed Actaea racemosa L; black cohosh). In particular, the invention is directed to an extract from Cimicifuga sp., preferably Cimicifuga racemosa, for use in the therapeutic or prophylactic treatment of diabetes, preferably diabetes mellitus type 2, the use of such extracts for preparing a medicament, corresponding pharmaceutical compositions comprising the extract as well as a method for the therapeutic or prophylactic treatment of diabetes, preferably by oral administration of the extract or pharmaceutical composition.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: January 3, 2023
    Assignee: MAX ZELLER SOEHNE AG
    Inventor: Georg Boonen
  • Petasites extract and composition and method for treating viral infections
    Patent number: 11285187
    Abstract: The present invention relates to a Petasites extract or pharmaceutical composition thereof for use in a method for treating viral infections.
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: March 29, 2022
    Assignee: MAX ZELLER SOEHNE AG
    Inventors: Jurgen Drewe, Stephan Toff, Catherine Zahner
  • Petasites extract and composition and method for treating viral infections
    Patent number: 10517912
    Abstract: The present invention relates to a Petasites extract or pharmaceutical composition thereof for use in a method for treating viral infections.
    Type: Grant
    Filed: March 15, 2016
    Date of Patent: December 31, 2019
    Assignee: MAX ZELLER SOEHNE AG
    Inventors: Jurgen Drewe, Stephan Toff, Catherine Zahner
  • PHARMACOLOGICAL USE OF CIMICIFUGA EXTRACT
    Publication number: 20150125555
    Abstract: The present invention relates to the novel use of an extract from a Cimicifuga species, preferably Cimicifuga racemosa (also termed Actaea racemosa L; black cohosh). In particular, the invention is directed to an extract from Cimicifuga sp., preferably Cimicifuga racemosa, for use in the therapeutic or prophylactic treatment of diabetes, preferably diabetes mellitus type 2, the use of such extracts for preparing a medicament, corresponding pharmaceutical compositions comprising the extract as well as a method for the therapeutic or prophylactic treatment of diabetes, preferably by oral administration of the extract or pharmaceutical composition.
    Type: Application
    Filed: July 3, 2013
    Publication date: May 7, 2015
    Applicant: MAX ZELLER SOEHNE AG
    Inventor: Georg Boonen
  • PHARMACEUTICAL COMPOSITION CONTAINING ACTIVE VEGETABLE SUBSTANCES
    Publication number: 20140010900
    Abstract: The invention relates to a pharmaceutical composition containing active vegetable substances and a mixture made of a polymeric water-soluble and a polymeric water-insoluble matrix forming agent. Said pharmaceutical composition is suitable for the oral administration of active vegetable substances with delayed release.
    Type: Application
    Filed: December 21, 2011
    Publication date: January 9, 2014
    Applicants: MAX ZELLER SÖHNE AG, MEPHA SCHWEIZ AG
    Inventor: Marco Spitz
  • Use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition and method for producing the same
    Patent number: 7914827
    Abstract: The present invention relates to the use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition, and to a method for producing the same.
    Type: Grant
    Filed: July 4, 2007
    Date of Patent: March 29, 2011
    Assignee: Max Zeller Soehne AG
    Inventor: Matthias-Heinrich Kreuter
  • Use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition and method for producing the same
    Publication number: 20090142423
    Abstract: The present invention relates to the use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition, and to a method for producing the same.
    Type: Application
    Filed: July 4, 2007
    Publication date: June 4, 2009
    Applicant: MAX ZELLER SOEHNE AG
    Inventor: Matthias-Heinrich Kreuter